Edward Maytin is a Dermatology physician affiliated with Cleveland State University. OpenAlex indexes 264 publications with 4,892 citations (h-index 44); ClinicalTrials.gov lists 10 registered studies matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Dermatology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingClinical trials
- Vitamin D Effects on Immune Microenvironment of Nonmelanoma Skin Cancer After Photodynamic Therapy (PDT)
Sponsor: Case Comprehensive Cancer Center
- Short Contact Protocols to Reduce Pain During 10% ALA Gel Red-light Photodynamic Therapy of Actinic Keratoses
Sponsor: Case Comprehensive Cancer Center
- Imaging Techniques to Monitor Photosensitizer and sO2 Levels During Photodynamic Therapy of Actinic Keratoses
Sponsor: Case Comprehensive Cancer Center
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Dermatology
86%Corticosteroid86%Triamcinolone Acetonide100%Part D≥241 patientsAnti-infectives
9%Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor9%Valacyclovir100%Part D≥21 patientsCancer & immunology
5%Nucleoside Metabolic Inhibitor5%Fluorouracil100%Part D≥11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
7 NIH research awards on record, funded 1999–2022 per NIH RePORTER. The latest:
- Vitamin D and Photodynamic Therapy for Human Skin Cancer (SCC and BCC)
Cleveland Clinic Lerner Com-Cwru
FY2022$390,309R01CA204158 - Vitamin D and Photodynamic Therapy for Human Skin Cancer (SCC and BCC)
Cleveland Clinic Lerner Com-Cwru
FY2021$452,052R01CA204158 - Vitamin D and Photodynamic Therapy for Human Skin Cancer (SCC and BCC)
Cleveland Clinic Lerner Com-Cwru
FY2020$464,550R01CA204158
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Significant improvement of facial actinic keratoses after blue light photodynamic therapy with oral vitamin D pretreatment: An interventional cohort-controlled trial
Journal of the American Academy of Dermatology
2022 - Vitamin D Receptor Activation and Photodynamic Priming Enables Durable Low-dose Chemotherapy
Molecular Cancer Therapeutics
2020 - Heparin inhibits proinflammatory and promotes anti-inflammatory macrophage polarization under hyperglycemic stress
Journal of Biological Chemistry
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Robert Modlin, MD
University of California, Los Angeles
Heidi Kong, MD
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Jon Hanifin, MD
Oregon Health & Science University (OHSU)
Victoria Werth, MD
Perelman School of Medicine at the University of Pennsylvania
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”